Breaks Categories: News

TuesdayNov 16, 2021 10:24 am

NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Reports Q3 Financial Numbers, Business Highlights

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art, signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, has released its Q3 2021 financial results as well as results for its  first nine months of 2021. Third-quarter revenue totaled $1,056,595 for the quarter with the company contracting for $1.2 million in new orders for LNA technology in the fourth quarter, resulting in AmpliTech increasing its order backlog to a record $3.35 million as of Nov. 15, 2021, compared to a $2.45 million backlog in August 2021. The company also signed a lease for…

Continue Reading

TuesdayNov 16, 2021 9:30 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) Announces Strategic Appointment of World-Renowned Immunologist and Cytokine Expert

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has announced the appointment of Eleanor N. Fish, Ph.D., to its research and clinical advisory board. Dr. Fish is an accomplished researcher in the areas of immunology and inflammatory disorders and a member of the government of Canada’s expert scientific panel to the chief scientific advisor. She brings key expertise to FSD Pharma that will support the continued development of FSD-PEA, the company’s proprietary anti-inflammatory agent, and Lucid-MS, its drug candidate for the treatment of multiple sclerosis.…

Continue Reading

MondayNov 15, 2021 3:08 pm

NetworkNewsBreaks – Global Fiber Technologies Inc. (GFTX) Subsidiary Enters Partnership to Offer NFT, Vinyl Record Bundles

Global Fiber Technologies (OTC: GFTX) announced that its subsidiary, Authentic Heroes Inc., has inked a letter of intent (“LOI”) to create a joint venture with Maestro Entertainment Corp. The agreement outlines the terms of licensing Maestro’s music catalog of more than 10,000 master recordings as well as leveraging Maestro’s industry relationships to pursue opportunities for combined venue. According to the announcement, the agreement will create a synergy between the companies. Initial collaboration will include creating and selling non-fungible music tokens along with vinyl records that will be available individually or bundled together. Maestro Entertainmenthas acquired the rights to more than 16,000 master song recordings from the 1940s,…

Continue Reading

MondayNov 15, 2021 2:32 pm

NetworkNewsBreaks — Roth Capital Partners Announces 10th Annual Technology Event

Roth Capital Partners, a full-service investment bank that has built a reputation for serving emerging growth companies, will be hosting the upcoming 10th annual Roth Technology Event; the event will be held virtually this year and is scheduled for Nov. 17–18, 2021. The gathering is designed to create opportunities for investors to meet one-on-one with executive management teams from more than 75 private and public sector companies that have interest or are operating in tech subsectors. These 40-minute video meeting provide in-depth insights and allow extensive interaction between companies and potential investors. “We have always focused our conferences on enabling…

Continue Reading

MondayNov 15, 2021 2:10 pm

NetworkNewsBreaks – Tingo Inc. (IWBB) Reports Q3 Results

Tingo (OTC: IWBB), a leading agri-fintech business in Africa, has released its unaudited financial results for the three and nine months ended September 30, 2021. Worth noting is that, on a proforma basis, IWBB’s wholly owned subsidiary, Tingo Mobile PLC, totaled revenues of $177 million and $317.5 million and operating income of $82 million and $170.2 million for the three and nine month periods, respectively. In addition, the report noted that as a percentage of overall revenue, income generated from Tingo’s NWASSA marketplace platform reached $56.5 million and $120.7 million for the three and nine months ended September 30, 2021; both figures…

Continue Reading

MondayNov 15, 2021 1:21 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2 2022 Financial, Business Report

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, has reported its financial and business updates for the second quarter of FY2022, the period ended Sept. 30, 2021. Notable highlights include the launch of Miboko, the company’s beta mass-market metabolic health program and the signing of a global commercial contract with MySugarWatch DuoPack Limited (“MSW-DP”). In addition, the company named Dr. Osama Hamdy, MD and PhD., as a new consultant on its advisory board as a consultant. Regarding the financial report, the company reported total operating expenses…

Continue Reading

MondayNov 15, 2021 1:03 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch delivery and monitoring device, software and data platform with Ei.Ventures’ proprietary psychedelic formulations. In addition, the two companies will work together on advancing Ei.Ventures’ research and development strategy. The partnership takes the two companies a step closer to negotiating and finalizing certain definitive research and…

Continue Reading

MondayNov 15, 2021 11:50 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes Acquisition of Vessel Brand Inc.

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed the acquisition of Vessel Brand Inc., an industry leader in cannabis consumer technology. According to Flora Growth, the acquisition provides the company with an immediate foothold in the North American cannabis market because Vessel brings with it a trailing 12-months revenue of $6.6 million and year-over-year growth of 90%. In addition, the acquisition diversifies Flora’s premium brand portfolio through Vessel’s strong position in the luxury cannabis consumer technology market. According to the announcement, key Vessel team members will join Flora’s executive bench and…

Continue Reading

MondayNov 15, 2021 11:31 am

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Completes Purchase of Tunica, Mississippi, EV Assembly Plant

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has closed on the purchase of an EV assembly plant located in Tunica, Mississippi. Mullen has purchased the Advanced Manufacturing and Engineering Center (“AMEC”) without any debt and now will focus on hiring the skilled trades and support staff needed to start initial preproduction class 1 and class 2 EV Cargo Vans. The purchase of AMEC is tied to the company’s previously announced plans to add another 1.2 million square feet of manufacturing space to the facility; the additional space will be designed to support class 1 and class 2…

Continue Reading

MondayNov 15, 2021 11:03 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q2 Financial Results, Business Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has released its unaudited second-quarter results and announced a conference call to review the report. The report covers the period ended Sept. 30, 2021. Highlights in the report included the company’s announcement of preclinical data for its novel deuterated psilocybin analog, CYB003, for the potential treatment of major depressive disorder and alcohol use disorder. The company has also been granted a Schedule I manufacturing license from the U.S. Drug Enforcement Agency for its Boston-area research lab and has received FDA approval to proceed with a company-sponsored…

Continue Reading